The launch environment has undergone huge changes as the pharmaceutical industry's focus has moved from primary care to specialty launch, but its future will be transformed even more radically. The advent of highly novel cell and gene therapies as well as prescription digital therapeutics is providing a serious set of forces for change in the market.
Other changes come from the challenges developed markets face, which renews the urgency for pharma companies to spread their launch successes beyond traditionally core markets.
The pressures exerted by these forces require companies' efforts in launch excellence to be able to 'square the circle' of better launch returns even as the launch environment becomes ever-more complex.
2019年9月11日从11-12 BST加入我们的网络研讨会，仔细研究了药物发布的过去，现在和未来。